Garmin (GRMN)
NYSEConsumer DiscretionaryHardware, Equipment & PartsSnapshot 2026-09-04
$277.03-0.05%
Close 2026-09-04 · 1-day change
NYSEConsumer DiscretionaryHardware, Equipment & PartsSnapshot 2026-09-04
Research Workspace
Put GRMN beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is slowing — up about 14% over the past year and decelerating.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, margins, the balance sheet.
View ManagementExpectations look high — the market is pricing in about 33% growth a year, above the roughly 14% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskGarmin's growth in the fitness segment has to keep compounding to justify the price. Revenue grew 11% year over year, and the last quarter beat expectations by 24%. It trades at 29× P/E versus a peer median of 15×, indicating the market is pricing in more growth than we forecast. If Garmin cuts guidance after recently raising it, that would damage credibility. Peer multiples imply a price about 33% below where it trades (it looks expensive on this basis). Our read is provisional.
Trailing returns as of 2026-09-04. GRMN is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 8 analysts currently covering GRMN (as of Sep 2026).
Based on 4 Wall Street analysts offering 12-month price targets for GRMN in the last 4 months.
Continue this research
Compare GRMN with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| GRMN Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Consumer Electronics — fair value, gap to price, and forward P/E.
Compare the value case
Put GRMN next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Expand product innovation across segments with new launches
New product launches enhance innovation and growth potential.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $277.03
The last 12 months of price, then the range of analyst 12-month targets from today’s $277.03.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Raise and achieve full year 2026 revenue and EPS guidance
Earnings beat supports revenue and EPS guidance for 2026.
Advances: Raise and achieve full year 2026 revenue and EPS guidance
Q2 earnings beat and raised guidance support growth objectives.
Advances: Raise and achieve full year 2026 revenue and EPS guidance
Strong demand supports revenue and EPS guidance for 2026.
Advances: Raise and achieve full year 2026 revenue and EPS guidance
Strong demand supports revenue and EPS guidance for 2026.
Concerns about sustainable growth impact revenue guidance.
Advances: Maintain revenue guidance for 2026
Revenue forecast exceeds guidance, supporting growth objectives.
Advances: Achieve pro forma EPS of $9.35 for 2026
Earnings call confirms EPS trajectory aligns with targets.